{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:03:37Z","timestamp":1773486217657,"version":"3.50.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,18]]},"DOI":"10.18632\/oncotarget.15441","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:33:37Z","timestamp":1487781217000},"page":"26245-26255","source":"Crossref","is-referenced-by-count":18,"title":["Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Xueju","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America"},{"name":"Department of Pathology, China-Japan Union Hospital of Jilin Province, Changchun, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra","family":"Dasari","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz S.","family":"Nowakowski","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos N.","family":"Lazaridis","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Wieben","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America"},{"name":"Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall E.","family":"Kadin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Department of Dermatology, Roger Williams Medical Center, Providence, Rhode Island, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Boddicker","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Jaffe","year":"2016","journal-title":"Blood"},{"key":"2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/asheducation-2008.1.280","article-title":"Prognosis and primary therapy in peripheral T-cell lymphomas","author":"Savage","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Billadeau","year":"2016","journal-title":"Blood"},{"key":"4","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/ijc.29081","article-title":"Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia","volume":"135","author":"de The","year":"2014","journal-title":"Int J Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2009.04.043","article-title":"Genomic antagonism between retinoic acid and estrogen signaling in breast cancer","volume":"137","author":"White","year":"2009","journal-title":"Cell"},{"key":"6","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.1158\/0008-5472.CAN-11-2091","article-title":"A comprehensive view of nuclear receptor cancer cistromes","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","article-title":"Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia","volume":"93","author":"Licht","year":"1999","journal-title":"Blood"},{"key":"8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/OTT.S61308","article-title":"The utility of bexarotene in mycosis fungoides and Sezary syndrome","volume":"8","author":"Scarisbrick","year":"2015","journal-title":"Onco Targets Ther"},{"key":"9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1396-0296.2003.01644.x","article-title":"Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2003","journal-title":"Dermatol Ther"},{"key":"10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0889-8588(03)00107-2","article-title":"Topical and systemic retinoid therapy for cutaneous T-cell lymphoma","volume":"17","author":"Burg","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1080\/1042819022386806","article-title":"Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma","volume":"43","author":"Liu","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1200\/JCO.1994.12.6.1185","article-title":"Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study","volume":"12","author":"Wang","year":"1994","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"Turner","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"31491","DOI":"10.1074\/jbc.M205016200","article-title":"Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers","volume":"277","author":"Chabot","year":"2002","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"publisher","first-page":"33280","DOI":"10.1074\/jbc.M002840200","article-title":"Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway","volume":"275","author":"Rochette-Egly","year":"2000","journal-title":"J Biol Chem"},{"key":"16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ajmg.c.31387","article-title":"Implementing individualized medicine into the medical practice","volume":"166C","author":"McCormick","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"17","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1128\/MCB.16.10.5386","article-title":"Analysis of the ligand-binding domain of human retinoic acid receptor alpha by site-directed mutagenesis","volume":"16","author":"Apfel","year":"1996","journal-title":"Mol Cell Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/sj.leu.2404118","article-title":"Relapse of acute promyelocytic leukemia with PML-RAR\u03b1 mutant subclones independent of proximate all-trans retinoic acid selection pressure","volume":"20","author":"Willman","year":"2006","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1805::AID-CNCR23>3.0.CO;2-0","article-title":"Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid","volume":"78","author":"Cheng","year":"1996","journal-title":"Cancer"},{"key":"20","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/1097-0142(19910515)67:10<2490::AID-CNCR2820671017>3.0.CO;2-Q","article-title":"13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma","volume":"67","author":"Wang","year":"1991","journal-title":"Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00277-011-1290-4","article-title":"Effects of tamibarotene for the treatment of adult T cell leukemia","volume":"91","author":"Matsumura","year":"2012","journal-title":"Ann Hematol"},{"key":"22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00432-007-0334-6","article-title":"Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia","volume":"134","author":"Kanamaru","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"23","first-page":"397","article-title":"RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells","volume":"31","author":"Tamura","year":"2007","journal-title":"Int J Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood.V99.6.2199","article-title":"Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1)","volume":"99","author":"Oberg","year":"2002","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6","article-title":"Regulation of G1\/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR)","volume":"78","author":"Wu","year":"1998","journal-title":"Int J Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1038\/sj.onc.1203821","article-title":"Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells","volume":"19","author":"Takeda","year":"2000","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1111\/j.1349-7006.2008.00917.x","article-title":"Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene)","volume":"99","author":"Mori","year":"2008","journal-title":"Cancer Sci"},{"key":"28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1128\/MCB.00756-09MCB.00756-09","article-title":"Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells","volume":"30","author":"Davidson","year":"2010","journal-title":"Mol Cell Biol"},{"key":"29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/cpr.12100","article-title":"Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells","volume":"47","author":"Zuckerman","year":"2014","journal-title":"Cell Prolif"},{"key":"30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1158\/0008-5472.CAN-08-2473","article-title":"A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis","volume":"69","author":"Hinds","year":"2009","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.leu.2405028","article-title":"Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma","volume":"22","author":"MacLeod","year":"2008","journal-title":"Leukemia"},{"key":"32","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Eckloff","year":"2012","journal-title":"Blood"},{"key":"33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/modpathol.2009.196","article-title":"CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma","volume":"23","author":"Merlio","year":"2010","journal-title":"Mod Pathol"},{"key":"34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","article-title":"Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone","volume":"326","author":"Kadin","year":"1992","journal-title":"N Engl J Med"},{"key":"35","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/MCB.25.3.1054-1069.2005","article-title":"c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha","volume":"25","author":"Kurie","year":"2005","journal-title":"Mol Cell Biol"},{"key":"36","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1182\/blood-2014-05-578575","article-title":"The oncogenic transcription factor IRF4 is regulated by a novel CD30\/NF-kappaB positive feedback loop in peripheral T-cell lymphoma","volume":"125","author":"Wu","year":"2015","journal-title":"Blood"},{"key":"37","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Mesirov","year":"2005","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:01:29Z","timestamp":1596722489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":37,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4,18]]}},"alternative-id":["15441","28412739"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15441","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}